
A signaling loop centering on the protein CD25 sustains the growth of acute leukemias such as #AML and #B-ALL by fine-tuning the activity of oncogenic tyrosine kinases, according to a new study. @MuschenLab @Yale scim.ag/4rMXddQ

B-cell dynamics, oncogenic signaling in B-cell malignancies @YaleUniversity. Since January 2026 @muschenlab.bsky.social

A signaling loop centering on the protein CD25 sustains the growth of acute leukemias such as #AML and #B-ALL by fine-tuning the activity of oncogenic tyrosine kinases, according to a new study. @MuschenLab @Yale scim.ag/4rMXddQ

Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia m.yale.edu/dfyw

On this week's cover of Science Signaling. Congratulations to Ruifeng Sun and Jaewoong Lee, who led this effort! Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia | Science Signaling science.org/eprint/ZZKJPHHXR…

EACR - Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy - ecancer ecancer.org/en/conference/15…

Beta-catenin promotes cancer cell growth but B-cell leukemia cells, unexpectedly, depend on its efficient degradation. Our paper out today in @naturecancer, shows how this dependency could be leveraged for the benefit of patients with B-ALL.👇 nature.com/articles/s43018-0…

👇In a few weeks, the Samir Zaidi Lab will open at Yale. Exciting and important science and a generous and supportive mentor - phenomenal opportunity for future graduate students and postdocs with an interest in lineage plasticity and drug resistance in cancer.
Fifteen years ago, my wife, Salimah, and I met as graduate students at @Yale in New Haven. Now, in a full-circle moment, I’m thrilled to share that I’ll be joining the @YaleCancer and @ynhhealth to launch my independent lab in March 2025! @samirzaidi I’ll be based in the Center of Molecular and Cellular Oncology and look forward to collaborating with incredible scientists like @BraunMDPhD, @ishizukalab, @S_J_Aitken, #CarolineMlynarczyk, #FrederickWilson and many others, under the leadership of @MuschenLab. I’m deeply grateful for the invaluable mentorship at @MSKCancerCenter ––from #CharlesSawyers @SawyersLabMSKCC, #MichaelMorris, @DrRosenbergMSK —who have guided me along this path. This transition wouldn’t have been possible without the unwavering support and vision of @DrEricWiner. His leadership made Yale feel not just like an exciting scientific home, but a truly warm and welcoming community—one that I can’t wait to be a part of. Excited to continue seeing patients in my clinic at @YaleCancer, and of course, to introduce our two boys to some legendary New Haven pizza!

Welcome back to Yale, Samir. So glad to have you joining us!
Fifteen years ago, my wife, Salimah, and I met as graduate students at @Yale in New Haven. Now, in a full-circle moment, I’m thrilled to share that I’ll be joining the @YaleCancer and @ynhhealth to launch my independent lab in March 2025! @samirzaidi I’ll be based in the Center of Molecular and Cellular Oncology and look forward to collaborating with incredible scientists like @BraunMDPhD, @ishizukalab, @S_J_Aitken, #CarolineMlynarczyk, #FrederickWilson and many others, under the leadership of @MuschenLab. I’m deeply grateful for the invaluable mentorship at @MSKCancerCenter ––from #CharlesSawyers @SawyersLabMSKCC, #MichaelMorris, @DrRosenbergMSK —who have guided me along this path. This transition wouldn’t have been possible without the unwavering support and vision of @DrEricWiner. His leadership made Yale feel not just like an exciting scientific home, but a truly warm and welcoming community—one that I can’t wait to be a part of. Excited to continue seeing patients in my clinic at @YaleCancer, and of course, to introduce our two boys to some legendary New Haven pizza!

New research presented at #ASH24 from the @MuschenLab by @RuifengSun2 shows the previously unrecognized role of PKCδ and CD25 in to control BCR signaling in Mature B-Cell #Lymphoma. @YaleMed @OncoAlert @YaleHematology ash.confex.com/ash/2024/webp…

.@RuifengSun2 presents research @MuschenLab showing CD25 as a regulator of the B pathway and suggesting it as a new therapeutic target for acute lymphoblastic leukemia #ALL at #ASH24. @YaleHematology @OncoAlert @YaleMed @YaleIBIO ash.confex.com/ash/2024/webp…

Zhangliang Cheng @MuschenLab presents on the 3 stages of B Cells and oscillations between MYC and BCL6 dependent states in B Cell #lymphoma. #ASH24 @YaleMed @SmilowCancer

Congratulations, both of you!
We all have our scientific role models. I’m so lucky that mine was my own mom. 1st-generation & running a lab while raising two boys, she overcame many barriers, to say the least. After 45 years of discoveries @MIT, I hope you enjoy retirement! news.mit.edu/2024/jane-jane-…

Leo Meriranta @Merijellona is defending his PhD thesis “molecular cross-section of high/risk #DLBCL” today. It is an honor to chair and enjoyable to listen high level scientific discussion lead by Dr Dan Hodson. Thank you Dan, well done Leo!


Welcome to Yale!
Super excited to share that we’ve moved to Yale University’s Department of Urology to continue our prostate cancer research. Already loving the Yale community and looking forward to some awesome collaborations ahead. @Yale_Urology @YaleMed @YaleCancer @Yale

Wonderful to be hosting Michael Reth @theNASciences , who discovered the ITAM and pioneer in immune receptor signaling. Thank you for an inspirational seminar @YaleIBIO and private brainstorming session over breakfast.

The ‘China Initiative’ failed US research and national security. Don’t bring it back. thehill.com/opinion/national…